Navigation Links
New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies
Date:12/18/2007

- Human Genome Sciences' ABthrax(TM) shows lifesaving potential - - HGS on track to deliver 20,000 doses to Strategic National Stockpile

beginning in 2008 -

ROCKVILLE, Md., Dec. 18 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that the results of two animal studies demonstrated the life-saving potential of its human monoclonal antibody drug ABthrax(TM) (raxibacumab). The results show that a single dose of ABthrax, administered without concomitant antibiotics, improved survival rates by up to 64 percent when administered after animals were symptomatic for anthrax disease as a result of inhalation exposure to massively lethal doses of anthrax spores. These dramatic and statistically significant findings demonstrate a survival benefit in two animal species, which is the requirement for establishing the efficacy of new drugs used to counter bioterrorism.

(Logo: http://www.newscom.com/cgi-bin/prnh/20010612/HGSLOGO )

"We believe that ABthrax offers a significant step forward in the treatment of inhalational anthrax, and could play an important role in strengthening America's arsenal against bioterrorism," said H. Thomas Watkins, President and Chief Executive Officer, HGS.

ABthrax, which specifically targets anthrax toxins and is being developed under contract with the Biomedical Advanced Research and Development Authority (BARDA), represents a new way to address the anthrax threat. While antibiotics can kill the Bacillis anthracis bacteria, they are not effective against the deadly toxins that the bacteria produce -- the real culprits in anthrax- related deaths. ABt
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Study Demonstrates Mindful Approach to Aging
2. Hillary Clinton Pledges Bold Approach to Stopping HIV/AIDS & Global Poverty
3. Raydiance Collaborates With Rutgers University and Nations Largest Tissue Bank to Develop Innovative Tissue Processing Approaches
4. Endoscopy Identified as Safe and Effective Method in Treating Common Complication of Gastric Bypass Surgery
5. New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
6. New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients With Complicated Skin Infections, Including MRSA
7. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
8. Promising Results in Treating Facial Bruising From Injectables
9. Evidence of Benefit Lacking for Many Common Ways of Treating Osteoarthritis of the Knee
10. New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients with Diabetic Foot Infections
11. Edwards Resilient Trial Demonstrates Statistically Superior Results for Treating Peripheral Arterial Disease in the Leg

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...ov. 20 Soligenix, Inc. (...y), formerly known as DOR BioPharma, Inc., a late-...it has formed a consortium to develop thermostable... acting vaccines. Soligenix received a $9.4 millio... Infectious Diseases (NIAID), a division of the Na...
(Date:11/19/2009)...ov. 19 In a series of ne..., Heska Corporation (Nasdaq: HSKA ) ("Heska" or t...w and improved website. The upgraded site is the ...rogramming to align the site with the company,s ne...go: http://www.newscom.com/cgi-bin/prnh/20000622...
(Date:11/19/2009)...Nov. 19 The D e al m...its Most Admired Corporate Dealmakers for the seco... its Most Admired Dealmaker in pharma/biotech for ...nd divestitures since January 2006. ,, Over the...tfolio with a focus on high-growth, innovation-dri...
Breaking Medicine Technology:Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3Response Times Vary for In Hospital Heart Attacks 53388 1Response Times Vary for In Hospital Heart Attacks 53388 2Blood Transfusions Not Linked to Long Term Problems 53386 1JAG Media Holdings Inc Announces Completion of Acquisition of CardioGenics Inc 53384 1JAG Media Holdings Inc Announces Completion of Acquisition of CardioGenics Inc 53384 2JAG Media Holdings Inc Announces Completion of Acquisition of CardioGenics Inc 53384 3JAG Media Holdings Inc Announces Completion of Acquisition of CardioGenics Inc 53384 4
... 10:00 a.m. today, Thursday, August 16, 2007, MAL... (Nasdaq: AUXL ) today announced that the Company...g Administration ("FDA") to,resume its phase III c...e,for injection), formerly referred to as AA4500, ...ompany will hold a conference call today,August 16...
...plemental New Drug Application in the Fourth ...ug. 16 Cephalon, Inc. (Nasdaq:,CEPH) today announ...cal,trial of FENTORA(R) (fentanyl buccal tablet) [...d with a broad range of chronic non-cancer pain,co...nce on the primary,endpoint. Results across the 12...
Other Medicine Technology:Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM) 2Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM) 3Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM) 4Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM) 5Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM) 6Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain 2Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain 3Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain 4Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain 5
(Date:11/21/2009)...nnovative medical apparel company launches men,s l... San Clemente, Calif. (PRWEB) November ...edical apparel, today announced the launch of its ...09, a leading international trade fair for the med...a inaugurates its men,s collection with three vary...
(Date:11/21/2009)...inwood Group ask whether there is a secret to ,alc... London, UK (PRWEB) November 2...e in three of the adult UK population drinking eno...-related liver disease*, it is hardly a surprise t...n programmes and residential centres for help. How...
(Date:11/20/2009)... Nov. 20 The United Sta...e to make essential changes its health reform bill... funding and conscience protection on abortion, pr...lude strong provisions for adequate affordability....ill an "enormous disappointment" that creates new ...
(Date:11/20/2009)... The American Dental As... Administration (FDA) to establish appropriate cla... Citing concern about the safety of whitening prod...it of professional consultation or examination by ...on of chemically based tooth whitening or bleachin...
(Date:11/20/2009)...0 The following is a st...e Nevada Health Care Association: ,, "The Nevad...ks Senate Majority Leader Harry Reid for his leade...r goal of protecting every Nevada seniors, ongoing...ng the strength and viability of our state,s vital...
Breaking Medicine News(10 mins):Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2
... of gene therapy is underway for muscular dystroph...l for Duchenne muscular dystrophy (DMD) tests the ...eloped over two decades by scientists at the Unive...dren's Hospital in Ohio, an affiliate of Ohio Stat...
...ning programme, launched by the UK Government has ... in the screening // process. The Department of He...in April, targeted at screening all 60 to 69 year ...he Cancer Research UK. The health department howev...
...en under the age of 15 die of AIDS every year - mo...s a new global report highlighting concerns about .../ The report by the World Health Organization (...tripled to 1.3 million in December 2005 from 400,0...
...V/AIDS in countries with high infection rates has .... // There was a stigma attached to the deadl...cted few decades ago and so AIDS testing was frown...e should now consider universal testing. As t...
...t by the UNH scientist, the beginning of 'natural ...fect, which is a result of global warming, has mad...eby creating a ripple effect in all the happenings...r Nature is increasingly getting a jumpstart on th...
... now revealed that men and women respond in unique... appropriate news media articles to regulate their...cles that would aggravate their anger while women ...highlights gender differences in anger management....
Other Medicine News:Health News:First Gene Therapy Human Trial For Muscular Dystrophy In Progress 2Health News:First Gene Therapy Human Trial For Muscular Dystrophy In Progress 3Health News:Delay In Life-Saving Bowel Cancer Screening Programme In UK 2Health News:AIDS Deaths On The Rise Due To Low Access To Antiretroviral Treatment 2Health News:‘Natural Spring’ Starts A Week Ahead Now Than Before: UNH Scienti 2Health News:‘Natural Spring’ Starts A Week Ahead Now Than Before: UNH Scienti 3Health News:Men And Women Read Different News To Manage Anger 2
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
Medicine Products: